Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÆÐÇ÷Áõ Sepsis

´ëÇѳ»°úÇÐȸÁö 2019³â 94±Ç 6È£ p.495 ~ 499
ÀÌ¿ëÈñ, Á¶¿µÀç,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ¿ëÈñ ( Lee Yung-Hee ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø È£Èí±â³»°ú

Á¶¿µÀç ( Cho Young-Jae ) 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø È£Èí±â³»°ú

Abstract


Diagnosis and treatment criteria were recently updated based on the Sepsis-3 guidelines, which recommend the sequential organ failure assessment for accurate characterization of organ dysfunction. Large randomized controlled trials have found neutral results with early goal-directed therapy. To improve outcomes, treatment bundles incorporating standards for early sepsis treatment, including antibiotic and steroid treatment, were developed. Thus, future research should address the effects of steroids and immune-modulating agents on refractory septic shock as well as the development of new coagulopathy therapies and dynamic assessment tools.

Å°¿öµå

Sepsis; Shock, Septic; Systemic inflammatory response syndrome

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS